The term "new drug" is generally associated with "new medicines" for diseases that have been difficult to treat in the past, but new drugs have made significant contributions to improving treatment outcomes and reducing the suffering of patients in their daily lives. New drugs that inhibit rejection after organ transplantation are one example. By developing new drugs for various roles, we aim to realize a healthy and long-lived society.
New drugs have contributed to medical care. For example, drugs for gastric and duodenal ulcers can now be treated without surgery. In addition, drugs for four diseases-hypertension, diabetes, dyslipidemia, and chronic hepatitis C-are also highly evaluated, with drug contribution rates of more than 90% (Source: Excerpt from the 2014 Domestic Basic Technology Survey Report by the Human Science Foundation).
